Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
Houston Methodist · Methodist Hospital · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,313
total citations
- FWCI
- 51.45
- Percentile
- 100%
- References
- 13
Citations per year
Authors
6Topics & keywords
Topics
Keywords
- Verteporfin
- Medicine
- Macular degeneration
- Photodynamic therapy
- Ranibizumab
- Ophthalmology
- Antiangiogenic therapy
- Optometry
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.